Yeter Haci Hasan, Manani Sabrina Milan, Ronco Claudio
Department of Nephrology Dialysis and Transplantation, Gazi University Faculty of Medicine, Ankara, Turkey.
Department of Nephrology Dialysis and Transplantation, San Bortolo Hospital, Vicenza, Italy.
Clin Kidney J. 2021 Jul 6;14(12):2483-2489. doi: 10.1093/ckj/sfab111. eCollection 2021 Dec.
Remote patient management (RPM) programs are one of the most crucial innovations in the peritoneal dialysis (PD) field that have been developed in the last decade. RPM programs are associated with favourable clinical outcomes by increasing the adherence of the patients to PD prescription. The literature supports that RPM is associated with increased blood pressure control and technique survival, and decreased hospitalization rate, length of hospital stay and health costs. RPM programs also facilitate patient follow-up during the coronavirus disease 2019 pandemic, increase treatment adherence and lead to better clinical outcomes. However, published data remain scarce and mainly consist of observational or retrospective studies with relatively low numbers of patients. Therefore, randomized controlled trial results will be more informative to demonstrate the effect of RPM programs on clinical outcomes.
远程患者管理(RPM)项目是过去十年中腹膜透析(PD)领域最重要的创新之一。RPM项目通过提高患者对PD处方的依从性,带来良好的临床效果。文献表明,RPM与血压控制改善、技术存活时间延长相关,还能降低住院率、住院时长和医疗成本。RPM项目在2019年冠状病毒病大流行期间也有助于患者随访,提高治疗依从性并带来更好的临床效果。然而,已发表的数据仍然稀缺,主要是观察性或回顾性研究,患者数量相对较少。因此,随机对照试验结果对于证明RPM项目对临床效果的影响将更具参考价值。